M. Yano et al., Ex vivo transfection of transforming growth factor-beta(1) gene to pulmonary artery segments in lung grafts, J THOR SURG, 117(4), 1999, pp. 705-712
Citations number
36
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective: Proximal pulmonary artery segment transfection may provide benef
icial downstream effects on the whole-lung graft. In this study, transformi
ng growth factor-beta(1) was transfected to proximal pulmonary artery segme
nts, and the efficacy of transforming growth factor-beta(1) transfection wa
s examined in ischemia-reperfusion injury and acute rejection models of rat
lung transplantation. Methods: In the ischemia-reperfusion injury model, o
rthotopic left lung transplantation was performed in F344 rats. In group I,
the PPAS was isolated and injected with saline solution. In 2 other groups
, lipid67:DOPE:sense (group TI) or antisense transforming growth factor-bet
a(1)pDNA construct (group III) was injected instead of saline solution. Aft
er cold preservation at 4 degrees C for 18 hours, lung grafts were implante
d. Graft function was assessed 24 hours later, In the acute rejection model
, donor lung grafts were harvested. Proximal pulmonary artery segments were
injected with saline solution (group I) or sense (group II) or antisense l
ipid gene construct (group III) and then implanted. Graft function was asse
ssed on postoperative day 5, Results: In the ischemia-reperfusion injury st
udy, there were no significant differences in oxygenation, wet-to-dry weigh
t ratios, graft myeloperoxidase activity, or transforming growth factor-bet
a(1) levels in platelet-poor serum or proximal pulmonary artery segment hom
ogenates. In the acute rejection study, oxygenation was significantly impro
ved in group II receiving transforming growth factor-beta(1) (group TT vs I
and III, 136.0 +/- 32.5 vs 54.0 +/- 9.6 mm Hg and 53.8 +/- 14.8 mm Hg; P =
.016 and .016). There were no significant pathologic differences. Transfor
ming growth factor-p, concentrations from proximal pulmonary artery segment
homogenates in group II were significantly higher compared with controls.
Conclusions: Ex vivo transfection of transforming growth factor-beta(1) to
proximal pulmonary artery segments did not affect reperfusion injury of lun
g isografts. In acute rejection, however, es vivo transfection of transform
ing growth factor-beta(1) to proximal pulmonary artery segments improved al
lograft function. This suggests that transfection to proximal pulmonary art
ery segments exerts beneficial downstream effects on the whole-lung allogra
ft.